MARTIN H. BROWN, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Williams in his article on beclomethasone dipropionate (1) consistently mentions, in his discussion of the treatment of acute asthma, supplementing aerosol therapy with oral or intravenous corticosteroid agents because of uncertain delivery of aerosol steroids in occluded airways. I believe that the use of this drug during an acute exacerbation of asthma may not only be hampered by its inability to reach the affected airway but also may be detrimental to the early reversal of bronchoconstriction.
Beclomethasone dipropionate is marketed in the United States by two pharmaceutical companies. These products are identical and contain beclomethasone dipropionate, oleic
BROWN MH. Aerosol Corticosteroids and Asthma. Ann Intern Med. 1982;96:253–254. doi: 10.7326/0003-4819-96-2-253_3
Download citation file:
Published: Ann Intern Med. 1982;96(2):253-254.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use